West Pharma (WST) Tops Q3 EPS by 6c, Revenues Beat; Reaffirms FY18 EPS Mid-Point Guidance Above Consensus, Offers FY18 Revenue Outlook
Go back to West Pharma (WST) Tops Q3 EPS by 6c, Revenues Beat; Reaffirms FY18 EPS Mid-Point Guidance Above Consensus, Offers FY18 Revenue Outlook| WEST PHARMACEUTICAL SERVICES, Inc. (NYSE: WST) | Delayed: 346.61 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $346.61 | 52 Week High | $84.33 | |||
| Open | $346.61 | 52 Week Low | $53.88 | |||
| Day High | $346.61 | P/E | 220.77 | |||
| Day Low | $346.61 | EPS | $1.57 | |||
| Volume | 13 | |||||
